This substance was identified for action under the Chemicals Management Plan (CMP).
|CAS RN||Common name||DSL name||Draft screening assessment||Proposed conclusion on section 64 criteria||Follow-up activities|
(Azodicarbonamide; 1,1’-Azobis(formamide); 1,1-Azobisformamide); diazene-1,2-dicarboxamide (C,C’-azodi(formamide))
|HTML||Does not meet||None planned at this time|
|April 2020||Anticipated publication of the final screening assessment.|
|April 20, 2019||Publication and start of 60-day public comment period on the draft screening assessment. The related notice was published in the Canada Gazette, Part I: Vol. 153, No. 16.|
Report a problem or mistake on this page
- Date modified: